This Boston-based biotech develops therapies for neurological disorders, with a pipeline targeting depression, tremor, and ...
Shares of Puma Biotechnology PBYI have tanked 9.6% in the past month, reflecting the growing investor concern regarding the ...
Vera Therapeutics develops clinical-stage therapies for serious immunological diseases, with a lead candidate targeting ...
The company's stock value has tanked before - it was once worth $1 billion.
Biotech picks highlight cystic fibrosis drug trials, rare-disease therapies and upcoming regulatory catalysts as clinical ...
This biotech specializes in precision therapies for rare genetic diseases, with a pipeline targeting oncology and hematology ...
Analyst Faisal Khurshid applauded Abivax's obefazimod, an oral drug developed to treat moderately to severely active ...
Biotech investors have rarely united so strongly against a Food and Drug Administration official as they did against Vinay ...
Learning how to trade biotech stocks offers some of the most explosive profit opportunities in the entire market—but also some of its most punishing risks. Biotech stocks can double or triple ...